4- [3- (4-CYCLOPROPANECARBONYL-PIPERAZINE-I-CARBONYL) -4 -FLUORO-BENZYL] -2H-PHTHALAZ IN-1-ONE

4- [3- (4-CYCLOPROPANECARBONYL-PIPERAZINE-I-CARBONYL) -4 -FLUORO-BENZYL] -2H-PHTHALAZ IN-1-ONE

4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-ben zyl]-2H-phthalazin-1-one as crystalline Form L, methods of obtaining form L, pharmaceutical compositions comprising Form L and methods of using Form L and compositions comprising Form L. 4-[3-(4-ciclopropancarbonil-piperacin-1-carbonil...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KATHRYN ANNE QUIGLEY, LEONARD JESSE CHYALL, EZRA JOHN STILL
Format: Patent
Sprache:eng ; spa
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-ben zyl]-2H-phthalazin-1-one as crystalline Form L, methods of obtaining form L, pharmaceutical compositions comprising Form L and methods of using Form L and compositions comprising Form L. 4-[3-(4-ciclopropancarbonil-piperacin-1-carbonil)-4-fluoro-bencil ]-2H-ftalacin-1-ona como Forma L cristalina, m?todos para obtener la Forma L, composiciones farmac?uticas que comprenden la Forma L y m?todos de uso de la Forma L y composiciones que comprenden la Forma L.